Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)

For making full use of aquatic by-products to produce high value-added products, Siberian sturgeon (Acipenser baerii) cartilages were degreased, mineralized, and separately hydrolyzed by five kinds of proteases. The collagen hydrolysate (SCH) generated by Alcalase showed the strongest 2,2-diphenyl-1...

Full description

Bibliographic Details
Published in:Marine Drugs
Main Authors: Sheng, Yan, Qiu, Yi-Ting, Wang, Yu-Mei, Chi, Chang-Feng, Wang, Bin
Format: Text
Language:English
Published: MDPI 2022
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146044/
http://www.ncbi.nlm.nih.gov/pubmed/35621976
https://doi.org/10.3390/md20050325
id ftpubmed:oai:pubmedcentral.nih.gov:9146044
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:9146044 2023-05-15T13:01:45+02:00 Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs) Sheng, Yan Qiu, Yi-Ting Wang, Yu-Mei Chi, Chang-Feng Wang, Bin 2022-05-14 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146044/ http://www.ncbi.nlm.nih.gov/pubmed/35621976 https://doi.org/10.3390/md20050325 en eng MDPI http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146044/ http://www.ncbi.nlm.nih.gov/pubmed/35621976 http://dx.doi.org/10.3390/md20050325 © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). CC-BY Mar Drugs Article Text 2022 ftpubmed https://doi.org/10.3390/md20050325 2022-06-05T00:58:11Z For making full use of aquatic by-products to produce high value-added products, Siberian sturgeon (Acipenser baerii) cartilages were degreased, mineralized, and separately hydrolyzed by five kinds of proteases. The collagen hydrolysate (SCH) generated by Alcalase showed the strongest 2,2-diphenyl-1-picrylhydrazyl radical (DPPH·) and hydroxide radical (HO·) scavenging activity. Subsequently, thirteen antioxidant peptides (SCP1-SCP3) were isolated from SCH, and they were identified as GPTGED, GEPGEQ, GPEGPAG, VPPQD, GLEDHA, GDRGAEG, PRGFRGPV, GEYGFE, GFIGFNG, PSVSLT, IELFPGLP, LRGEAGL, and RGEPGL with molecular weights of 574.55, 615.60, 583.60, 554.60, 640.64, 660.64, 885.04, 700.70, 710.79, 602.67, 942.12, 714.82, and 627.70 Da, respectively. GEYGFE, PSVSLT, and IELFPGLP showed the highest scavenging activity on DPPH· (EC(50): 1.27, 1.05, and 1.38 mg/mL, respectively) and HO· (EC(50): 1.16, 0.97, and 1.63 mg/mL, respectively), inhibiting capability of lipid peroxidation, and protective functions on H(2)O(2)-damaged plasmid DNA. More importantly, GEYGFE, PSVSLT, and IELFPGLP displayed significant cytoprotection on HUVECs against H(2)O(2) injury by regulating the endogenous antioxidant enzymes of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) to decrease the contents of reactive oxygen species (ROS) and malondialdehyde (MDA). Therefore, the research provided better technical assistance for a higher-value utilization of Siberian sturgeon cartilages and the thirteen isolated peptides—especially GEYGFE, PSVSLT, and IELFPGLP—which may serve as antioxidant additives for generating health-prone products to treat chronic diseases caused by oxidative stress. Text Acipenser baerii Siberian sturgeon PubMed Central (PMC) Marine Drugs 20 5 325
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Article
spellingShingle Article
Sheng, Yan
Qiu, Yi-Ting
Wang, Yu-Mei
Chi, Chang-Feng
Wang, Bin
Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
topic_facet Article
description For making full use of aquatic by-products to produce high value-added products, Siberian sturgeon (Acipenser baerii) cartilages were degreased, mineralized, and separately hydrolyzed by five kinds of proteases. The collagen hydrolysate (SCH) generated by Alcalase showed the strongest 2,2-diphenyl-1-picrylhydrazyl radical (DPPH·) and hydroxide radical (HO·) scavenging activity. Subsequently, thirteen antioxidant peptides (SCP1-SCP3) were isolated from SCH, and they were identified as GPTGED, GEPGEQ, GPEGPAG, VPPQD, GLEDHA, GDRGAEG, PRGFRGPV, GEYGFE, GFIGFNG, PSVSLT, IELFPGLP, LRGEAGL, and RGEPGL with molecular weights of 574.55, 615.60, 583.60, 554.60, 640.64, 660.64, 885.04, 700.70, 710.79, 602.67, 942.12, 714.82, and 627.70 Da, respectively. GEYGFE, PSVSLT, and IELFPGLP showed the highest scavenging activity on DPPH· (EC(50): 1.27, 1.05, and 1.38 mg/mL, respectively) and HO· (EC(50): 1.16, 0.97, and 1.63 mg/mL, respectively), inhibiting capability of lipid peroxidation, and protective functions on H(2)O(2)-damaged plasmid DNA. More importantly, GEYGFE, PSVSLT, and IELFPGLP displayed significant cytoprotection on HUVECs against H(2)O(2) injury by regulating the endogenous antioxidant enzymes of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) to decrease the contents of reactive oxygen species (ROS) and malondialdehyde (MDA). Therefore, the research provided better technical assistance for a higher-value utilization of Siberian sturgeon cartilages and the thirteen isolated peptides—especially GEYGFE, PSVSLT, and IELFPGLP—which may serve as antioxidant additives for generating health-prone products to treat chronic diseases caused by oxidative stress.
format Text
author Sheng, Yan
Qiu, Yi-Ting
Wang, Yu-Mei
Chi, Chang-Feng
Wang, Bin
author_facet Sheng, Yan
Qiu, Yi-Ting
Wang, Yu-Mei
Chi, Chang-Feng
Wang, Bin
author_sort Sheng, Yan
title Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
title_short Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
title_full Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
title_fullStr Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
title_full_unstemmed Novel Antioxidant Collagen Peptides of Siberian Sturgeon (Acipenser baerii) Cartilages: The Preparation, Characterization, and Cytoprotection of H(2)O(2)-Damaged Human Umbilical Vein Endothelial Cells (HUVECs)
title_sort novel antioxidant collagen peptides of siberian sturgeon (acipenser baerii) cartilages: the preparation, characterization, and cytoprotection of h(2)o(2)-damaged human umbilical vein endothelial cells (huvecs)
publisher MDPI
publishDate 2022
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146044/
http://www.ncbi.nlm.nih.gov/pubmed/35621976
https://doi.org/10.3390/md20050325
genre Acipenser baerii
Siberian sturgeon
genre_facet Acipenser baerii
Siberian sturgeon
op_source Mar Drugs
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146044/
http://www.ncbi.nlm.nih.gov/pubmed/35621976
http://dx.doi.org/10.3390/md20050325
op_rights © 2022 by the authors.
https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
op_rightsnorm CC-BY
op_doi https://doi.org/10.3390/md20050325
container_title Marine Drugs
container_volume 20
container_issue 5
container_start_page 325
_version_ 1766285534464835584